A randomized, double-blind, placebo-controlled, cross-over trial of oxytocin in patients with autism spectrum disorder
Phase 2
- Conditions
- autism spectrum disorder
- Registration Number
- JPRN-UMIN000007250
- Lead Sponsor
- Research Center for Child Mental Development, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of allergy for oxytocin 2. History of traumatic brain injury with loss of consciousness for more than 5 minutes 3. Diagnosed as having substance dependence or history of substance dependence 4. History of water intoxication 5. Routinely severe polydipsia 6. Clinical judgment of ineligility for some reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method